Stock Alert: Novavax Up 6% As Phase 3 Trial Of COVID-19 Vaccine Initiated

RTTNews

25 Sep 2020 0 shares 1 views

Stock Alert: Novavax Up 6% As Phase 3 Trial Of COVID-19 Vaccine Initiated

RTTNews

Published 25 Sep 2020

Shares of Novavax, Inc. (NVAX) are gaining nearly 6% on Friday morning on news that the biotechnology company has commenced late-stage trial study of its COVID-19 vaccine.

Full Article

Stock Alert: CureVac Up 6% After Initiating Phase 2 Trial Of COVID-19 Vaccine

RTTNews 30 Sep 2020

Shares of CureVac N.V. (CVAC) are gaining over 6% on Wednesday morning. Tuesday after the bell, CureVac announced that it has..

Stock Alert: Windtree Therapeutics Jumps 22% As FDA Accepts IND Application For COVID-19 Treatment
RTTNews 29 Sep 2020
Dow ends 400+ points up in reversal of last week's selloff
Proactive Investors 28 Sep 2020
Wall Street looking strong to open the week
Proactive Investors 28 Sep 2020
Wall Street rises at the opening bell
Proactive Investors 28 Sep 2020

More coverage

Stock Alert: Inovio Pharma Plummets 30% As FDA Puts On Hold Its Coronavirus Vaccine

RTTNews 28 Sep 2020

Shares of Inovio Pharmaceuticals, Inc. (INO) tanked 30% on Monday morning after the biotechnology company announced that phase 2/3..

Inovio stock plunges more than 34% as FDA puts Covid-19 vaccine trial on hold
bizjournals 28 Sep 2020
Drugmaker Novavax begins late-stage vaccine trial in UK
SeattlePI.com 25 Sep 2020
Novavax surges 10% after it begins phase 3 trial of COVID-19 vaccine
Business Insider 25 Sep 2020
Coronavirus latest: Novavax launches first phase 3 Covid vaccine trial
FT.com 24 Sep 2020

Stock Alert: Novavax Up 6% As Phase 3 Trial Of COVID-19 Vaccine Initiated

Stock Alert: Novavax Up 6% As Phase 3 Trial Of COVID-19 Vaccine Initiated

You might like

Related news coverage

Stock Alert: CureVac Up 6% After Initiating Phase 2 Trial Of COVID-19 Vaccine

Advertisement

More coverage

Stock Alert: Inovio Pharma Plummets 30% As FDA Puts On Hold Its Coronavirus Vaccine